Prognostic Value of Pharmacologic Stress Echocardiography in Patients With Idiopathic Dilated Cardiomyopathy: A Prospective, Head-to-Head Comparison Between Dipyridamole and Dobutamine Test

Journal of Cardiac Failure

Volumn 13, Issue 10, 2007, Pages 836-842

  Pratali, Lorenza ^a   Otasevic, Petar ^b   Neskovic, Aleksandar ^b   Molinaro, Sabrina ^a   Picano, Eugenio ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Idiopathic dilated cardiomyopathy; prognosis; stress echocardiography

Indexed keywords

AMINOPHYLLINE; DIPYRIDAMOLE; DOBUTAMINE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONGESTIVE CARDIOMYOPATHY; DEATH; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; HYPOTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STRESS ECHOCARDIOGRAPHY; SURVIVAL;

CARDIOMYOPATHY, DILATED; CARDIOTONIC AGENTS; DIPYRIDAMOLE; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VASODILATOR AGENTS;

EID: 36749042580     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.07.011     Document Type: Article

References (34)

1. Picano E., Sicari R., Landi P., et al. The prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation 98 (1998) 1078-1084
2. Picano E., Landi P., Bolognese L., et al., The EPIC Study Group. Prognostic value of dipyridamole-echocardiography early after uncomplicated myocardial infarction: a large-scale multicenter trial. Am J Med 11 (1993) 608-618
3. Sicari R., Ripoli A., Picano E., et al., VIDA (Viability Identification with Dipyridamole Administration) Study Group. The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischemic left ventricular dysfunction. Eur Heart J 22 (2001) 837-844
4. Sicari R., Picano E., Cortigiani L., et al., VIDA (Viability Identification with Dobutamine Administration) Study Group. The prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol 92 (2003) 1263-1266
5. Paelinck B., Vermeersch P., Stockman D., Convesr C., and Vaerenberg M. Usefulness of low-dose dobutamine stress echocardiography in predicting recovery of poor left ventricular function in atrial fibrillation dilated cardiomyopathy. Am J Cardiol 83 (1999) 1668-1671
6. Naqvi T.Z., Goel R.K., Forrester J.S., and Siegel R.J. Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol 34 (1999) 1537-1544
7. Kitaoka H., Takata J., Yabe T., Hitomi N., Furuno T., and Doi Y.L. Low dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function in dilated cardiomyopathy. Heart 81 (1999) 523-527
8. Scrutinio D., Napoli V., Passantino A., Ricci R., Lagioia R., and Rizzon P. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome. Eur Heart J 21 (2000) 927-934
9. Pratali L., Picano E., Otasevic P., et al. Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy. Am J Cardiol 88 (2001) 1374-1378
10. Paraskevaidis I.A., Adamopoulos S., and Kremastinos D.T. Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study. J Am Coll Cardiol 37 (2001) 1685-1691
11. Drozdz J., Krzeminska-Pakula M., Plewka M., Ciesielczyk M., and Kasprzak J.D. Prognostic value of low-dose dobutamine echocardiography in patients with idiopathic dilated cardiomyopathy. Chest 121 (2002) 1216-1222
12. Pinamonti B., Perkan A., Di Lenarda A., Gregori D., and Sinagra G. Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications. Eur J Heart Fail 4 (2002) 49-61
13. Paraskevaidis I.A., Adamopoulos S., Tsiapras D., Karatzas D., and Kremastinos D.T. Prognostic usefulness of echocardiographic dobutamine in younger (14 to 25 years) and older (40 to 55 years) patients with idiopathic dilated cardiomyopathy. Am J Cardiol 93 (2004) 251-255
14. Pratali L., Otasevic P., Rigo F., Gherardi S., Neskovic A., and Picano E. The additive prognostic value of restrictive pattern and dipyridamole-induced contractile reserve in idiopathic dilated cardiomyopathy. Eur J Heart Fail 7 (2005) 844-851
15. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 44 (1980) 672-673
16. Picano E., Mathias Jr. W., Pingitore A., Bigi R., and Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 344 (1994) 1190-1192
17. Ranhosky A., and Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. Circulation 81 (1990) 1205-1209
18. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of left ventricle by two-dimensional echocardiography. (American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms). J Am Soc Echocardiogr 2 (1989) 358-367
19. Armstrong W.F., Pellikka P.A., Ryan T., Crouse L., and Zoghbi W.A. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 11 (1998) 97-104
20. Picano E., Marzullo P., Gigli G., et al. Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest. Am J Cardiol 70 (1992) 703-710
21. Varga A., Ostojic M., Djordjevic-Dikic A., et al. Infra-low dose dipyridamole test. A novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography. Eur Heart J 17 (1996) 629-634
22. Pingitore A., Picano E., Varga A., et al. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 34 (1999) 1769-1777
23. Gregg D.E. Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circ Res 13 (1963) 497-500
24. Torres M.A., Picano E., Parodi G., et al. Flow-function relation in patients with chronic coronary artery disease and reduced regional function. A positron emission tomographic and two-dimensional echocardiographic study with coronary vasodilator stress. J Am Coll Cardiol 30 (1997) 65-70
25. Biaggioni I., Olafsson B., Robertson R.M., et al. Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res 61 (1987) 779-786
26. Lucarini A.R., Picano E., Marini C., et al. Activation of sympathetic tone during dipyridamole test. Chest 102 (1992) 444-447
27. Ely S.W., and Berne R.M. Protective effects of adenosine in myocardial ischemia. Circulation 85 (1992) 893-904
28. Kusmic C., Petersen C., Picano E., et al. Antioxidant effect of oral dipyridamole during cerebral hypoperfusion with human carotid endoarterectomy. J Cardiovasc Pharmacol 36 (2000) 141-145
29. Kusmic C., Picano E., Busceti C.L., et al. The antioxidant drug dipyridamole spares the vitamin E and thiols in red blood cells after oxidative stress. Cardiovasc Res 47 (2000) 510-514
30. Iuliano L., Pedersen J., Rotilio G., et al. A potent chain-breaking antioxidant activity of cardiovascular drug dipyridamole. Free Radic Biol Med 18 (1995) 239-247
31. Picano E., Lattanzi F., Orlandini A., Marini C., and L'Abbate A. Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol 17 (1991) 666-669
32. Ciampi Q., and Villari B. Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction. Cardiovasc Ultrasound 5 (2007) 27-32
33. Fioretti P.M., Poldermans D., Salustri A., et al. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J 15 (1994) 355-360
34. Djordjevic-Dikic A., Ostojic M., Beleslin B., et al. Low-dose adenosine stress echocardiography: detection of myocardial viability. Cardiovasc Ultrasound 1 (2003) 1-7